Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

ATTOAttovia Therapeutics, Inc.

Nasdaq · CIK 0002058707
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC2836 Biological Products, (No Diagnostic Substances)
FY end1231
XBRL facts148

Identity from submissions API

NameAttovia Therapeutics, Inc.
CIK0002058707
TickersATTO
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC2836 Biological Products, (No Diagnostic Substances)
EIN921510574
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone5103995001
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)1

Former names

  • None listed.
Business address
1091 INDUSTRIAL ROAD
SAN CARLOS
CA
94070
CA
Mailing address
1091 INDUSTRIAL ROAD
SAN CARLOS
CA
94070
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

61 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000905148-26-004977 005-95859 261563022 34 36642
2026-11-13 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000886982-26-000642 005-95859 261554214 34 32994
2026-11-13 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002148983-26-000005 005-95859 261552844 34 6650
2026-11-09 10-Q 10-Q 0001193125-26-453622 001-43423 261536159 34 11244517 1 1
2026-11-09 8-K 8-K 2.02,8.01 0001193125-26-453592 001-43423 261536012 34 407286 1 1
2026-10-08 4/A xslF345X06/form4a-10092026_121054.xml 0001644888-26-000009 6149
2026-10-08 4/A xslF345X06/form4a-10082026_111058.xml 0001654907-26-000009 6182
2026-10-08 3/A xslF345X06/form3a-10082026_111032.xml 0001644888-26-000008 18347
2026-10-08 3/A xslF345X06/form3a-10082026_111047.xml 0001654907-26-000008 13902
2026-09-02 10-Q 10-Q 0001193125-26-380228 001-43423 261355104 34 10455793 1 1
2026-09-02 8-K 8-K 2.02,9.01 0001193125-26-380215 001-43423 261355025 34 388648 1 1
2026-08-28 144 xsl144X01/primary_doc.xml 0000891836-26-000065 001-43423 261341768 33 4788
2026-08-28 4/A FORM 4/A 0001866174-26-000011 69750
2026-08-28 4/A FORM 4/A 0000886982-26-000522 80578
2026-08-13 4 FORM 4 0001866174-26-000009 55995
2026-08-13 4 FORM 4 0000886982-26-000495 66811
2026-08-12 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-003341 005-95859 261267349 34 11322
2026-08-11 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0001231919-26-000857 005-95859 261264315 34 37341
2026-08-10 4 4 0001193125-26-342487 11390
2026-08-10 4 FORM 4 0000905148-26-003548 16324
2026-08-07 4 OWNERSHIP DOCUMENT 0001104659-26-092867 16085
2026-08-07 4 4 0001193125-26-340173 10024
2026-08-06 4 xslF345X06/form4-08062026_090845.xml 0001231919-26-000838 24507
2026-08-06 4 4 0001193125-26-338446 5369
2026-08-06 4 xslF345X06/form4-08062026_090835.xml 0001242882-26-000004 5613
2026-08-06 4 xslF345X06/form4-08062026_090834.xml 0002141590-26-000008 5643
2026-08-06 4 xslF345X06/form4-08062026_090833.xml 0002141655-26-000008 5640
2026-08-06 4 xslF345X06/form4-08062026_090836.xml 0002142262-26-000006 5636
2026-08-06 4 4 0001193125-26-338430 001-43423 261250381 34 5714
2026-08-06 4 4 0001193125-26-338420 001-43423 261250363 34 5732
2026-08-06 8-K 8-K 5.03,9.01 0001193125-26-338037 001-43423 261249193 34 396615 1 1
2026-08-06 S-8 S-8 0001193125-26-336011 333-298035 261245461 33 240152 1 1
2026-08-05 3 xslF345X06/form3-08052026_110859.xml 0002148983-26-000002 4182
2026-08-05 3 FORM 3 0001866174-26-000007 7911
2026-08-05 424B4 424B4 0001193125-26-334997 333-297452 261243191 33 9645768
2026-08-04 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-002535 333-297452 261241079 33 1737
2026-08-04 3 3 0001193125-26-333469 8957
2026-08-04 3 OWNERSHIP DOCUMENT 0001104659-26-090604 9622
2026-08-04 3 3 0001193125-26-333417 11771
2026-08-04 3 FORM 3 0000905148-26-003465 15885
2026-08-04 3 3 0001193125-26-333385 20777
2026-08-04 3 xslF345X06/form3-08042026_110813.xml 0002141655-26-000006 17078
2026-08-04 3 xslF345X06/form3-08042026_110839.xml 0001727703-26-000005 10314
2026-08-04 3 3 0001193125-26-333377 001-43423 261240783 34 22255
2026-08-04 3 xslF345X06/form3-08042026_110811.xml 0002141590-26-000006 17276
2026-08-04 3 3 0001193125-26-333373 001-43423 261240774 34 26923
2026-08-04 3 xslF345X06/form3-08042026_110836.xml 0001168404-26-000046 13218
2026-08-04 3 3 0001193125-26-333371 17433
2026-08-04 3 xslF345X06/form3-08042026_110804.xml 0002142262-26-000004 15571
2026-08-04 3 3 0001193125-26-333362 16754
2026-08-04 3 FORM 3 0000886982-26-000301 19009
2026-08-04 3 xslF345X06/form3-08042026_100847.xml 0001231919-26-000827 14130
2026-08-04 3 3 0001193125-26-333095 5823
2026-08-04 CERT 8A_CERT_ATTO_0002058707.pdf 0001354457-26-000753 001-43423 261236953 34 181196
2026-08-04 S-1/A S-1/A 0001193125-26-331510 333-297452 261235377 33 9885481 1 1
2026-07-29 8-A12B 8-A12B 0001193125-26-323646 001-43423 261217349 34 14189
2026-07-29 S-1/A S-1/A 0001193125-26-323618 333-297452 261217284 33 11477205 1 1
2026-07-14 S-1 S-1 0001193125-26-303256 333-297452 261174611 33 11860961 1 1
2026-06-05 DRS/A filename1.htm 0001193125-26-259800 377-08845 261069882 33 10062763
2026-02-12 DRS/A filename1.htm 0001193125-26-048782 377-08845 26626482 33 6787627
2025-12-19 DRS filename1.htm 0001193125-25-326945 377-08845 251587923 33 8374165

Latest XBRL company facts

One latest value per concept from companyfacts (148 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 45.71M 2026-10-31 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
ffd NetFeeAmt NetFeeAmt USD 14,638.33 2026-08-05 S-8 2026-08-06 0001193125-26-336011
ffd TtlFeeAmt TtlFeeAmt USD 14,638.33 2026-08-05 S-8 2026-08-06 0001193125-26-336011
ffd TtlOfferingAmt TtlOfferingAmt USD 106.00M 2026-08-05 S-8 2026-08-06 0001193125-26-336011
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-08-05 S-8 2026-08-06 0001193125-26-336011
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 33,748.19 2026-08-04 S-1/A 2026-08-04 0001193125-26-331510
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 4.22M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 539,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 5.35M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 219,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 1.83M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -548,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 570.91M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings USD 2.40M 2025-07-01 2025-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 3.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 4.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap Assets Assets USD 411.82M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap AssetsCurrent Assets, Current USD 404.52M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap AvailableForSaleDebtSecuritiesGrossUnrealizedGain Debt Securities, Available-for-sale, Unrealized Gain USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap AvailableForSaleDebtSecuritiesGrossUnrealizedLoss Debt Securities, Available-for-sale, Unrealized Loss USD 558,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 280.57M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 115.37M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 115.77M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 75.17M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 8.29M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 500.00M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 45.69M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 45.68M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap CommonStockValue Common Stock, Value, Issued USD 5,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -62.26M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap ConversionOfStockAmountIssued1 Conversion of Stock, Amount Issued USD 258.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap ConvertiblePreferredStockSharesIssuedUponConversion Convertible Preferred Stock, Shares Issued upon Conversion shares 21.52M 2026-08-06 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap DebtSecuritiesAvailableForSaleAmortizedCostCurrent Debt Securities, Available-for-sale, Amortized Cost, Current USD 281.13M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount USD 200,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap Depreciation Depreciation USD 488,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-09-02 0001193125-26-380228
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 700,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 736,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap DividendsPayableCurrentAndNoncurrent Dividends Payable USD 0 2026-06-30 2026 Q2 10-Q 2026-09-02 0001193125-26-380228
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -4.86 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -4.86 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap EmployeeBenefitsAndShareBasedCompensation Employee Benefits and Share-based Compensation USD 9.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 2.90M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 11.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 1.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD 157,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap IncreaseDecreaseInDebtSecuritiesTrading Increase (Decrease) in Debt Securities, Trading USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -1.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD 486,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 3.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap InterestReceivable Interest Receivable USD 2.50M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 5.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 4.10M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 2.33M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 1.20M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 567,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 262,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap Liabilities Liabilities USD 14.08M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 411.82M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap LiabilitiesCurrent Liabilities, Current USD 11.67M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap ManufacturingCosts Manufacturing Costs USD 40.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap MarketableSecuritiesUnrealizedGainLoss Marketable Securities, Unrealized Gain (Loss) USD -469,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 306.16M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -170.38M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -60.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -61.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -61.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 Noncash or Part Noncash Acquisition, Fixed Assets Acquired USD 6,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap NoncashOrPartNoncashAcquisitionPayablesAssumed1 Noncash or Part Noncash Acquisition, Payables Assumed USD 709,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-09-02 0001193125-26-380228
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 5.17M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap OperatingExpenses Operating Expenses USD 67.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -66.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 1.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 3.84M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 2.10M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 1.74M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 3.17M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 193,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 586,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax USD -647,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 672,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -86,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap OtherResearchAndDevelopmentExpense Other Research and Development Expense USD 2.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 3.71M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 276.81M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 378,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap PreferredStockAccretionOfRedemptionDiscount Preferred Stock, Accretion of Redemption Discount USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap PreferredStockLiquidationPreferenceValue Preferred Stock, Liquidation Preference, Value USD 255.85M 2026-06-30 2026 Q2 10-Q 2026-09-02 0001193125-26-380228
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 8.58M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 331,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale USD 106.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 78,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-09-02 0001193125-26-380228
us-gaap ProfessionalFees Professional Fees USD 2.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 4.98M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 3.15M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 55.98M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap RestrictedCash Restricted Cash USD 404,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 115.77M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 404,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -172.62M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap Revenues Revenues USD 450,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 3.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 16.30M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 1.25M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 4.11 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 1.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 41,556 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 4.17 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 1.83M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 10.58 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 34.25M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 4.32M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 9.25 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value USD 34.25M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number shares 4.32M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price USD/shares 9.25 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 2.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 2.85 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 16.4 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 397.74M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 116,040 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 305.34M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 1.63M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 289,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap TemporaryEquityAccretionToRedemptionValue Temporary Equity, Accretion to Redemption Value USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 258.23M 2025-12-31 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap TemporaryEquityLiquidationPreference Temporary Equity, Liquidation Preference USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap TreasuryStockCommonShares Treasury Stock, Common, Shares shares 8,074 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap TreasuryStockCommonValue Treasury Stock, Common, Value USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 12.68M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation Weighted Average Number of Shares, Common Stock Subject to Repurchase or Cancellation shares 282,773 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 12.68M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622
us-gaap WriteOffOfDeferredDebtIssuanceCost Write off of Deferred Debt Issuance Cost USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453622

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →